AstraZeneca is the latest pharma company enlisting the services of Chinese biotechs, signing a deal worth up to $5.2bn with ...

Entering the era of agentic AI will shift investment to agentic experiences, but keeping humans at the center of the customer ...

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured ...

Here is a close look at AppLovin stock, including where the shares of the tech company could be headed through the rest of ...

AstraZeneca has signed a deal worth up to $5.2bn to work with a Chinese biotech company using AI to develop new treatments for chronic diseases.

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

The integration of Artificial Intelligence (AI) in various sectors has been nothing short of transformative, and now, it’s poised to ...

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is one of the 13 Biotech Stocks with Huge Upside Potential. Jazz Pharmaceuticals plc ...

The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump ...

A hearing this week marked a critical juncture in the national conversation about the intersection of biotechnology, privacy, ...

Biased AI models may lead to results that don’t accurately reflect populations. For example, if a dataset on which a model is ...